Metsera Inc. is a New York-based biotechnology company developing innovative long-acting injectable and oral therapies specifically designed to treat obesity. The company focuses on creating differentiated therapeutic solutions that address the growing global obesity epidemic through advanced drug delivery mechanisms. Metsera's approach centers on developing treatments that offer improved patient compliance and sustained efficacy compared to existing obesity management options. By leveraging novel formulation technologies and targeting mechanisms, the company aims to provide healthcare providers and patients with more effective tools for long-term weight management and metabolic health improvement in the expanding obesity therapeutics market.